18+

Research Use Only — Adults 18+ Only. All products sold by PepHQ, LLC are for research, laboratory, and analytical purposes only. Not intended for human consumption, therapeutic use, or medical application. By continuing to browse, you confirm you are 18 or older and agree to our Terms of Use.

Research Articles

Scientific insights and research findings on peptide applications in laboratory studies.

February 2026

Triple-Receptor Agonism in Metabolic Research

Research Focus: GLP-3 RT

Exploring the synergistic effects of simultaneous GLP-1, GIP, and glucagon receptor activation in laboratory metabolic studies.

Key Findings:

▸Superior weight reduction compared to single-receptor approaches in preclinical models
▸Enhanced glucose homeostasis through multi-pathway activation
▸Dose-dependent metabolic improvements across multiple markers
▸Potential applications in obesity and diabetes research

References:

PMC (May 2025). "Triple Receptor Agonism in Obesity Pharmacotherapy." Comprehensive review of novel triple receptor agonists.

PMC (2025). "Triple Agonism Based Therapies for Obesity." Analysis of GLP-1 receptor agonists transformation in obesity research. Cited by 8.

Nature (November 2025). "Cardiovascular Outcomes of Semaglutide and Tirzepatide." Cohort studies assessing effectiveness and safety profiles.

View Product Details →

January 2026

Copper Peptides in Regenerative Research

Research Focus: GHK-Cu

Comprehensive review of GHK-Cu's mechanisms in tissue repair, collagen synthesis, and cellular regeneration processes.

Key Findings:

▸Modulation of 4,000+ genes with focus on DNA repair pathways
▸25.4-fold increase in collagen IV synthesis when combined with hyaluronic acid
▸Demonstrated wound healing acceleration in diabetic models
▸Anti-inflammatory effects comparable to corticosteroids in research settings

References:

ResearchGate (October 2025). "The Effect of GHK-Cu on Stem Cell Actions." Gene profiling data demonstrating GHK-Cu's potential in stem cell therapy.

PMC (2025). "Exploring the Beneficial Effects of GHK-Cu on Experimental Ulcerative Colitis." Anti-inflammatory properties research. Cited by 1.

PMC (2025). "Topically Applied GHK as an Anti-Wrinkle Peptide." Analysis of advantages and prospective for topical GHK applications.

VitaLifeMD (November 2024). "New Research & Discoveries from 2024." GHK peptide's ability to reset gene expression patterns.

View Product Details →

December 2025

Neuroprotective Peptides in Cognitive Research

Research Focus: Semax

Investigation of BDNF-enhancing peptides and their applications in neurological research and cognitive function studies.

Key Findings:

▸Increased BDNF and NGF production supporting neuronal growth
▸Neuroprotective effects against oxidative stress and beta-amyloid accumulation
▸Improved cognitive markers in attention and memory research
▸Potential applications in stroke recovery and neurodegenerative research

References:

British Journal of Pharmacology (July 2025). "Semax Peptide Targets the μ Opioid Receptor Gene Oprm1." RNA-seq analysis revealing novel mechanisms.

PMC (2025). "The Potential of Semax and Its Derivative for Neuroprotection." Comprehensive assessment of neuroprotective effects.

Journal of Restorative Medicine (2024). "Improving Biological Age, Telomere Length, and Cognition: Case Report." Clinical case demonstrating Semax applications. Cited by 1.

Neurochemical Journal (2025). "IP Ashmarin and the Study of Neurotropic Activity of Regulatory Peptides." Comprehensive review of Semax neurotropic activity.

View Product Details →

Research Use Only: All articles reference laboratory research and preclinical studies. Products are not intended for human consumption or therapeutic use.